The latest closing stock price for MaxCyte as of November 20, 2024 is 3.49.
An investor who bought $1,000 worth of MaxCyte stock at the IPO in 2021 would have $-795 today, roughly -1 times their original investment - a -41.01% compound annual growth rate over 3 years.
The all-time high MaxCyte stock closing price was 17.20 on September 03, 2021.
The MaxCyte 52-week high stock price is 5.54, which is 58.7% above the current share price.
The MaxCyte 52-week low stock price is 3.17, which is 9.2% below the current share price.
The average MaxCyte stock price for the last 52 weeks is 4.33.
An investor who bought $1,000 worth of MaxCyte stock at the IPO in 2021 would have $-795 today, roughly -1 times their original investment - a -41.01% compound annual growth rate over 3 years.
The all-time high MaxCyte stock closing price was 17.20 on September 03, 2021.
The MaxCyte 52-week high stock price is 5.54, which is 58.7% above the current share price.
The MaxCyte 52-week low stock price is 3.17, which is 9.2% below the current share price.
The average MaxCyte stock price for the last 52 weeks is 4.33.